SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg8/1/2005 4:22:49 PM
   of 1022
 
Cuba and Indonesia Join to Fight Cancer

Havana, Aug 1 (AIN) Cuba and Indonesia signed a bilateral cooperation accord in Jakarta to develop and produce a Cuban monoclonal antibody known as 1E10 expected to be very effective to fight cancer.

The agreement was signed during the official presentation in Indonesia of the Innogene Kalbiotech company, a subsidiary of Kalbe Farma, one of the major Indonesian enterprises in the biotechnological sector which maintains relations with Cuban scientific institutions.

The Cuban 1E10 monoclonal antibody is produced by the island's Molecular Inmunology Center.

The agreement implements a cooperation project considered crucial for both the Cuban and the Indonesian biotechnological sectors and which is expected to make way for other important joint actions in that field.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext